News
Miiskin introduces new first of its kind automatic imaging technology to support skin monitoring for patients at home.
This morning BioIQ, a health-testing and biometric-screening technology company, released its at-home COVID-19, Flu A/Flu B, and 21 Test Respiratory Panel saliva test.
The news comes months after reports that the company had furloughed staff and couldn't secure additional funding for its-ingestible sensor business.
A new enterprise offering called Ready for Work will use devices, apps and dashboards to conduct daily screening for COVID-19 symptoms.
The study indicated that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection.
The long-awaited decision is the first regulatory authorization for Akili, and the first game-based therapeutic that the FDA has greenlit for any condition.
The retail giant has purchased CareZone's tech platform, patents and IP.
The system is able to continuously transmit glucose data every minute.
From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.
New funding will develop key markets and launch the company’s US presence.